Southern California Clinical Research Inc - CA Los Angeles, Pasadena 91106

Southern California Clinical Research Inc entered the industry of Health Services in 2011 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 621999, which describes it as a Health Services. For further clarification, the SIC classifies this business under the code 8099 and described it as a Health Services. The business provides service to the B2C market.

To acquire more information, please contact by calling (626) 844-8848 during business hours. You can also write to the business’ Single Location at 600 South Lake Avenue # 105, Pasadena, California CA 91106. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Southern California Clinical Research Inc
Place of Business: 600 South Lake Avenue # 105, Pasadena, CA 91106
Contact Number: (626) 844-8848
Type of Service: Health Services
SIC Number: 8099
NAICS Number: 621999
Locality: Single Location
Market Type: B2C (Business to Consumer)
Began: 2011
Income/Year: $100.000 to $499.999
Laborers: 1 to 4
Share This Company:

Southern California Clinical Research Inc is a company operating from Los Angeles, California providing professional Health Services and relevant B2C variables. It was founded in 2011 and registered with the SIC code 8099 as Health Services, and with the NAICS code 621999 as Health Services.

With a current employee count of 1 to 4, Southern California Clinical Research Inc has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative at (626) 844-8848 for related queries, or to locate its Single Location using the coordinates 34.135659,-118.132115.

The Single Location can also be found at the street address 600 South Lake Avenue # 105 in Pasadena, California 91106 and can be engaged online through the company website at , the company Twitter , and Facebook page .